Trial Profile
Safety of OctaplasLG in patients with thrombotic microangiopathic anemias (TMA) undergoing plasma exchange
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Plasma (Primary)
- Indications Thrombotic microangiopathies; Thrombotic thrombocytopenic purpura
- Focus Adverse reactions
- 31 Aug 2016 New trial record